Categories: Wire Stories

Cell and Gene Therapy Industry Comes Together for Matica Bio�s New Global Event

COLLEGE STATION, Texas–(BUSINESS WIRE)–Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies, hosted an inaugural event this week, Global Cell & Gene Day, with CHA Medical & Bio Group, providing a specialized venue for learning, innovation and networking for the advancing cell and gene therapy market.

Matica Bio has extensive experience in the clinical and commercial production of cell and gene therapies and recently opened its new 25,000-square-foot GMP facility in Texas dedicated to the production of viral vectors and cell-based products used in cell and gene therapies, vaccines, oncolytic therapies and other genetic medicines.

�Matica Bio understands the important role ongoing collaborations have in order to keep pace with this industry’s accelerated clinical development time frames, production complexities and increased demand,” said Matica Bio CEO Yun Jeong Song, M.D. “These include building opportunities for key industry interactions and discussions through events such as Global Cell & Gene Therapy Day, as well as establishing partnerships like ones we have in place with Sartorius and Texas A&M University’s Center for Innovation in Advanced Development and Manufacturing. It is essential that we are all working together as an industry for the future expansion of research, expertise, and successful product development.”

Over 400 attended Global Cell & Gene Day in Pangyo, South Korea. Speakers and topics in the program included a market overview from McKinsey & Co., a discussion on venture capital investment trends from Bain Capital and a summary of clinical trials and regulations from Parexel. Together with these industry experts, Matica Bio shared updates on CMC drug development. Presentations from this event can be made available by request.

Additional events from Matica Bio will be shared at: https://www.maticabio.com/news-upcoming-event.

About Matica Biotechnology, Inc.

Matica Biotechnology is a CDMO specialized for fully integrated cell and gene therapy manufacturing. The industry-leading experts at our state-of-the-art facility in College Station, Texas, deliver breakthrough therapies rapidly and safely through innovative manufacturing solutions. Advance your therapy from idea to patient with the experts at Matica Biotechnology. Visit www.maticabio.com.

Contacts

Lindsey Langemeier

SCORR Marketing

402-405-4269

lindsey@scorrmarketing.com

Alex

Recent Posts

Score 11 Unbeatable Deals This 11.11 on Shopee with 90% Off Lowest Price Guaranteed

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 8 November 2024 - It’s that time…

46 mins ago

Shenzhen China Wins the World Smart City Award, Demonstrating the Global Influence of Social Intelligent Governance of Mega City

BARCELONA, SPAIN - Media OutReach Newswire - 8 November 2024 - On November 6, Central…

2 hours ago

Singapore – A Trusted Global Supply Chain Management Hub

SINGAPORE - Media OutReach Newswire - 8 November 2024 - Singapore is strengthening its position…

3 hours ago

OPPO Celebrates Global Photography Talent at Paris Photo Fair under the theme of “Dear Life”

PARIS, FRANCE - Media OutReach Newswire – 8 November 2024 - This year, OPPO once…

4 hours ago

ICONSIAM Showcases Thai Culture with “ICONSIAM THAICONIC LOY KRATHONG” Festival, Strengthening Thailand’s Global Standing

This year’s Loy Krathong event at ICONSIAM celebrates Thai cultural heritage, promotes sustainability, and shines…

4 hours ago

KBTG Vietnam and Techsauce Propel Techsauce Global Summit 2024 in Vietnam – Accelerating ASEAN’s Digital Economy

HO CHI MINH CITY, VIETNAM – Media OutReach Newswire – 8 November 2024 - KBTG…

5 hours ago